Table 4.

HRs for 7-year CVD and all-cause death associated with WC/HHcy groups.

	NWC/HHcy (–)	NWC/HHcy (+)	HWC/HHcy (–)	HWC/HHcy (+)
	(n = 897, 24.4%)	(n = 599, 16.3%)	(n = 1,305, 35.5%)	(n = 874, 23.8%)
CVD death
Case	19	26	35	55
Mortality	2.1%	4.3%	2.7%	6.3%
Model 1	1.00	2.12 (1.17, 3.83)*	1.26 (0.72, 2.19)	3.16 (1.87, 5.32)*
Model 2	1.00	1.34 (0.73,2.46)	1.13 (0.64, 2.00)	1.79 (1.05, 3.07)*
Model 3	1.00	1.36 (0.74, 22.51)	1.06 (0.60, 1.89)	1.75 (1.02, 3.03)*
All-cause death
Case	80	100	110	164
Mortality	8.9%	16.7%	8.4%	18.7%
Model 1	1.00	1.74 (1.24, 2.50)*	0.94 (0.70, 1.25)	2.24 (1.71,2.92)*
Model 2	1.00	1.23 (1.02,1.67)*	0.90 (0.67,1.21)	1.36 (1.18,2.20)*
Model 3	1.00	1.16 (0.94,1.60)	0.82 (0.60,1.12)	1.23 (1.04,2.18)*

NWC, normal WC (<90 cm for men and <80 cm for women); HWC, higher WC (≥90 cm for men and ≥80 cm for women); HHcy (–): without HHcy; HHcy (+): with HHcy.

NWC/HHcy (–) group used as reference.

^*P <0.05.

Model 1: Unadjusted.

Model 2: Data adjusted for age, sex, current smoking, current drinking and activity.

Model 3: Data adjusted for age, sex, current smoking, current drinking, activity, hypolycemia therapy, lipid-lowering therapy and creatinie.

WC, waist circumference; HHcy, hyperhomocysteinamia; CVD, cardiovascular disease; HR, hazard ratio.